1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Geron Corporation – Product Pipeline Review – 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s pharmaceuticals report, “Geron Corporation - Product
Pipeline Review - 2012” provides data on the Geron Corporation’s research and
development focus. The report includes information on current developmental
pipeline, complete with latest updates, and features on discontinued and dormant
projects.
This report is built using data and information sourced from Global Markets Direct’s
proprietary databases, Geron Corporation’s corporate website, SEC filings, investor
presentations and featured press releases, both from Geron Corporation and
industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Geron Corporation - Brief Geron Corporation overview including business
description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Geron Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
Table of contents:
List of Tables 5
2. List of Figures 6
Geron Corporation Snapshot 7
Geron Corporation Overview 7
Key Information 7
Key Facts 7
Geron Corporation – Research and Development Overview 8
Key Therapeutic Areas 8
Geron Corporation – Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products – Monotherapy 11
Pipeline Products – Combination Treatment Modalities 12
Geron Corporation – Pipeline Products Glance 13
Geron Corporation Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Geron Corporation – Early Stage Pipeline Products 15
Pre-Clinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
Geron Corporation – Drug Profiles 17
GRN1005 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
GRN163L 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
GRN163L + Paclitaxel + Bevacizumab 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
GRN163L + Paclitaxel + Carboplatin 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
3. GRN510 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Hepatocytes 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:
Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline
Review – 2012&PubId=&pagenum=1
Genta Incorporated – Product Pipeline Review – 2012
Geron Corporation – Product Pipeline Review – 2012
Glenmark Pharmaceuticals Ltd. – Product Pipeline Review – 2012
iBio, Inc. – Product Pipeline Review – 2012
ImmunoGen, Inc. – Product Pipeline Review – 2012
Can-Fite BioPharma Ltd. – Product Pipeline Review – 2012
4. Celtic Biotech, Ltd. – Product Pipeline Review – 2012
Cyclacel Pharmaceuticals Inc. – Product Pipeline Review – 2012
Endocyte, Inc. – Product Pipeline Review – 2012
Flamel Technologies S.A. – Product Pipeline Review – 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com